Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by Dandy07on Jun 12, 2020 2:12pm

261 Views

Post# 31144389

Lvl II

Last:

0.045

Change:

-0.005

Volume:

257,000

Last Trade:

13:21

Level ll Quote
Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders

$0.045	258000	2	$0.05	578000	11
$0.04	4797000	37	$0.055	418000	14
$0.035	2081000	24	$0.06	318000	8
$0.03	1314000	19	$0.065	389000	8
$0.025	700000	13	$0.07	471000	8
$0.02	480000	11	$0.075	195000	5
$0.015	301000	5	$0.08	601000	11
$0.01	500000	1	$0.085	179000	3
			$0.09	280000	4
			$0.095	101000	3